- Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes
-
Yang SC, Lee DH, Hong SJ, Chung BH, Kim IY
- KMID: 699944
- Yonsei Med J.
- 1997 Jun;38(3):155-159.
- doi: 10.3349/ymj.1997.38.3.155
The enzyme telomerase maintains a constant telomere length in immortalized cells, allowing unlimited cell proliferation. Almost all cancer cells express telomerase activity. However, little data is available regarding... -
- CITED
-
- Close
- SHARE
-
- Close
- The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients
-
Lee DH, Yang SC, Hong SJ, Chung BH, Chung HJ, Tokunaga H, Kim IY, Song YS, Lerner SP, Morton RA
- KMID: 711624
- Yonsei Med J.
- 1999 Apr;40(2):118-123.
- doi: 10.3349/ymj.1999.40.2.118
Transforming growth factor-beta (TGF-beta), a pleiotropic growth factor, is a potent inhibitor of cellular proliferation in cells of epithelial origin. Recently, it has been suggested that a loss... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
-
Lim SD, Cho YM, Choi GS, Park HK, Paick SH, Kim WY, Kim SN, Yoon G
- KMID: 2164501
- J Korean Med Sci.
- 2015 Aug;30(8):1068-1077.
- doi: 10.3346/jkms.2015.30.8.1068
The study aimed to verify the prognostic utility, therapeutic application and clinical benefits of tumor substaging and HER2 status in papillary non-muscle invasive bladder cancer (NMIBC). Select NMIBC transurethral resection... -
- CITED
-
- Close
- SHARE
-
- Close
